Woodline Partners’s Capricor Therapeutics CAPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.18M Sell
137,655
-81,431
-37% -$2.17M 0.02% 690
2025
Q4
$6.32M Buy
219,086
+208,969
+2,066% +$2.73M 0.02% 570
2025
Q3
$72.9K Sell
10,117
-231,527
-96% -$1.7M ﹤0.01% 868
2025
Q2
$2.4M Sell
241,644
-487,674
-67% -$5.15M 0.01% 699
2025
Q1
$6.92M Buy
729,318
+99,384
+16% +$1.38M 0.05% 429
2024
Q4
$8.69M Buy
+629,934
New +$11M 0.06% 378
2024
Q2
Sell
-12,461
Closed -$84.6K 569
2024
Q1
$84.6K Sell
12,461
-897,081
-99% -$4.34M ﹤0.01% 525
2023
Q4
$4.45M Buy
+909,542
New +$2.96M 0.05% 329

Other funds holding CAPR